Hernandez, I. (2017). Revisiting Outcomes–Based Pricing Propositions for the PCSK9 Inhibitor Evolocumab. JAMA Intern Med.
Čikaški stil citiranjaHernandez, Inmaculada. "Revisiting Outcomes–Based Pricing Propositions for the PCSK9 Inhibitor Evolocumab." JAMA Intern Med 2017.
MLA način citiranjaHernandez, Inmaculada. "Revisiting Outcomes–Based Pricing Propositions for the PCSK9 Inhibitor Evolocumab." JAMA Intern Med 2017.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.